Show simple item record

dc.contributor.advisorRoss, Ashley Hilton Adrian
dc.contributor.authorGryn, Agnieszka
dc.date.accessioned2009-04-21T13:40:33Z
dc.date.available2009-04-21T13:40:33Z
dc.date.issued2007
dc.identifier.other310400
dc.identifier.urihttp://hdl.handle.net/10321/401
dc.descriptionMini-dissertation submitted in partial compliance with the requirements of the Master's Degree in Technology: Homoeopathy in the Faculty of Health Sciences at the Durban University of Technology, 2007en
dc.description.abstractThe homoeopathic drug proving of Erythrina lysistemon 30CH took a form of a randomised triple–blind, placebo–controlled study. This trial was conducted at the Homoeopathic Day Clinic on the premises of Durban University of Technology. The research group consisted of 32 provers, which were recruited from amongst practicing homoeopaths, homoeopathic students (2`nd–5`th year), as well as patients of the Homoeopathic Day Clinic (DUT) and their relatives. The participation was purely on voluntary basis. Provers were randomly divided into two groups: a placebo group of 12; a proving group of 20. Each researcher supervised 8 provers. Neither the provers, nor the researchers were aware of the name or nature of the substance being proved, and whether a prover is receiving a placebo or the proving substance until the unblinding process. Provers had a homoeopathic case history taken and a physical examination performed on them before commencement of the proving to establish each individual’s baseline. Provers were required to keep journals in which they recorded their sign and symptoms: starting 7 days prior to commencing the proving, throughout the proving, as well as after administration of the remedy formulated. All the information gathered was then correlated and interpreted by the researchers i.e. four M.Tech.Hom students. Subsequent translation of the symptoms into materia medica and repertory language took place. On completion of the proving a homoeopathic picture of the remedy with III distinct affinities was established. Those affinities were then compared to the toxicology of the major chemical constituents of Erythrina lysistemon. Data was then analyzed by qualitative methods for it was not amendable to standard statistical analysis.en
dc.format.extent197 pen
dc.language.isoenen
dc.subjectErythrinaen
dc.subjectHomeopathy--Materia medica and therapeuticsen
dc.subjectAlternative medicineen
dc.subjectHomeopathyen
dc.titleA comparison of the results from the proving of Erythrina lysistemon 30CH, with toxicology of the crude substanceen
dc.typeThesisen
dc.dut-rims.pubnumDUT-000442


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record